ORIGINAL RESEARCH article
Front. Immunol.
Sec. Inflammation
Serum Paraoxonase-1 as a Marker of Oxidative Stress and Pulmonary Dysfunction in Sarcoidosis: Association with Disease Activity and Prognostic Potential
Provisionally accepted
- Ankara Etlik City Hospital, Ankara, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Objectives: Sarcoidosis is a multisystem granulomatous disorder characterized by an oxidative imbalance and inflammatory activation. Paraoxonase-1 (PON1) is a high-density lipoprotein– associated antioxidant enzyme that plays a protective role against oxidative stress. This study aimed to evaluate the serum PON1 activity in patients with sarcoidosis, its relationship with disease stage, and its association with pulmonary function and routine biochemical parameters. Materials and Methods: A total of 45 patients with sarcoidosis and 45 age-and sex-matched healthy controls were included. Complete blood counts, biochemical parameters, and pulmonary function test results were evaluated. Serum PON1 activity was colorimetrically determined using a commercial kit. Statistical analyses included correlation, logistic regression, receiver operating characteristic (ROC) curves, and partial least squares discriminant analysis (PLS-DA). Results: Serum PON1 activity was significantly lower in patients with sarcoidosis than in the healthy controls (p<0.001). PON1 levels showed strong positive correlations with FEV₁ (r=0.835), FVC (r=0.807), and DLCO (r=0.905), indicating that decreased antioxidant capacity parallels impaired pulmonary function. ROC analysis demonstrated that PON1 effectively differentiated patients from controls (AUC=0.838; sensitivity, 75%; specificity, 82% at ≤210.53 U/L). PON1 levels declined progressively with increasing disease stages (p<0.05). Logistic regression analysis revealed that higher BMI and reduced FEV₁ were independent predictors of sarcoidosis, whereas PON1 lost significance after adjusting for covariates. Conclusion: Serum paraoxonase activity is markedly reduced in sarcoidosis and is correlated with disease severity and pulmonary dysfunction, suggesting increased oxidative stress. Although not an independent predictor, PON1 may serve as a useful adjunctive biomarker, particularly for evaluating disease severity in Stage II and advanced stages, rather than for early diagnosis.
Keywords: antioxidant enzyme, biomarker, Oxidative Stress, Paraoxonase-1, pulmonaryfunction tests, Sarcoidosis
Received: 24 Oct 2025; Accepted: 16 Dec 2025.
Copyright: © 2025 Bozkürk, Gunay, Ogan, Candemir, Eker and Ozturk. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Mine Büşra Bozkürk
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.